Stocks and InvestingStocks and Investing
Fri, April 9, 2021
Thu, April 8, 2021
Wed, April 7, 2021
Tue, April 6, 2021
Mon, April 5, 2021

Joseph Stringer Maintained (ACAD) at Strong Buy with Decreased Target to $30 on, Apr 5th, 2021


Published on 2024-10-27 16:06:56 - WOPRAI, Joseph Stringer
  Print publication without navigation


Joseph Stringer of Needham, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Strong Buy with Decreased Target from $44 to $30 on, Apr 5th, 2021.

Joseph has made no other calls on ACAD in the last 4 months.



There are 9 other peers that have a rating on ACAD. Out of the 9 peers that are also analyzing ACAD, 4 agree with Joseph's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Tazeen Ahmad of "B of A Securities" Downgraded from Strong Buy to Hold on, Wednesday, March 10th, 2021
  • Yatin Suneja of "Guggenheim" Downgraded from Strong Buy to Hold on, Tuesday, March 9th, 2021
  • Neena Bitritto-Garg of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $35 on, Tuesday, March 9th, 2021
  • Paul Matteis of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $27 on, Tuesday, March 9th, 2021


These are the ratings of the 5 analyists that currently disagree with Joseph


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $43 on, Tuesday, March 9th, 2021
  • Danielle Brill of "Raymond James" Downgraded from Strong Buy to Buy and Decreased Target to $35 on, Tuesday, March 9th, 2021
  • Jeffrey Hung of "Morgan Stanley" Maintained at Buy with Decreased Target to $50 on, Tuesday, March 9th, 2021
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $40 on, Tuesday, March 9th, 2021
  • Vamil Divan of "Mizuho" Initiated at Strong Buy and Held Target at $69 on, Wednesday, December 16th, 2020